JAGX stock

Jaguar Animal Health Inc (JAGX) stock news · rev $11.5M

Jaguar Animal Health Inc (JAGX) is a biotechnology company listed on NASDAQ.

This JAGX news page leads with what Jaguar Animal Health Inc filed — not a scraped headline mill.

No cached 8-K sentence for JAGX yet. We will not pad this page with generic market recap.

Latest reported JAGX revenue for 2025-12-31 was $11.5M. Net income was -$53.6M. Revenue was down 1.5% from 2024-12-31 to 2025-12-31. JAGX currently screens at market cap $1.7M.

EDGAR remains the official archive. Lician caches the exhibit so you can read what changed without a wire story.

Not investment advice. For the model open the JAGX stock page; for the tape open the quote page.

JAGX stock news FAQ

What are JAGX's latest revenue and net income?

Latest cached Jaguar Animal Health Inc (JAGX) revenue for Dec 31, 2025 was $11.5M. Net income was -$53.6M. Statements: https://lician.com/financials/jagx

How did JAGX revenue change from the prior cached period?

Cached Jaguar Animal Health Inc (JAGX) revenue was down 1.5% from $11.7M (Dec 31, 2024) to $11.5M (Dec 31, 2025). Statements: https://lician.com/financials/jagx

What is JAGX's market cap?

Jaguar Animal Health Inc (JAGX) market cap is $1.7M on the latest cached fundamentals snapshot.

What kind of company is JAGX?

Jaguar Animal Health Inc (JAGX) is a biotechnology company listed on NASDAQ.

Where is JAGX stock news listed?

Cached stock news for Jaguar Animal Health Inc (JAGX) is listed at https://lician.com/news/jagx. Filings: https://lician.com/sec/jagx

Not investment advice.

Full JAGX analysis